D-tagatose as anti-hyperglycemic agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 18, 1994
Grant Date -
N/A
app pub date -
Feb 14, 1992
filing date -
Feb 14, 1992
priority date (Note) -
In Force
status (Latency Note)
Importance
|
US Family Size
|
Non-US Coverage
|
|
Patent Longevity
|
Forward Citations
|
Abstract
This invention discloses the usefulness of D-tagatose as a treatment for hyperglycemia, diabetes mellitus, and the inhibition of formation of advanced glycosylation end-products associated with the aging process. This invention discloses edible formulations and pharmaceutical compositions containing D-tagatose and the effect of consumption of such formulations on blood level of glucose. D-Tagatose was found to be an anti-hyperglycemic agent. In addition, consumption of D-tagatose in sweetened formulations to inhibit formation of advanced glycosylation end-products in mammals is disclosed. The combination of the anti-hyperglycemic effect and the inhibition of formation of glycosylated proteins and nucleic acids make D-tagatose an ideal agent for alleviating the complications resulting from hyperglycemia, including acceleration of the aging process.
First Claim
Other Claims data not available
Family
- No Family data available.
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
- 12 Citation Count
- A61K Class
- 71.08 % this patent is cited more than
- 31 Age